SAR-445710

N/A

Report date: 2024/06/28 10:19:38

Base Information

Drug NameSAR-445710

Drug Alias NameKD-033SAR-445710

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed death-ligand 1 blockersInterleukin-15 receptor subunit alpha agonists

TargetsProgrammed death-ligand 1Interleukin-15 receptor subunit alpha

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTakeda Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKadmon Corporation Llc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A